Skip to main content
Discovering the causes of cancer and the means of prevention
 

Laufey Aumundadottir Receives 2021 CCR-DCEG FLEX Award

, by DCEG Staff

Laufey Amundadottir, Ph.D., senior investigator in the Laboratory of Translational Genomics, in collaboration with Dr. Efsun Arda from the NCI Center for Cancer Research (CCR), have received the 2021 CCR-DCEG FLEX award, for their project “Characterizing cell type resolved effects of genetic variation on pancreas cancer risk.” 

About the CCR-DCEG Flex Program 

CCR and DCEG pursue highly complementary approaches to cancer research and prevention. To foster integrative studies that take advantage of expertise in population-based epidemiological studies in DCEG and basic biology and clinical research in CCR, the FLEX program awards proposals for the formation of joint research teams to perform high-impact, collaborative research projects in the area of cancer mechanism, diagnosis, prognosis, susceptibility, predisposition, or prevention. Learn more about the program CCR-DCEG Flex Award program.

< Older Post

COVID-19 Research by DCEG Featured in NCI Cancer Currents Blog

Newer Post >

COVID-19 Research Across the Division: DCEG Experts Address the Pandemic

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Laufey Aumundadottir Receives 2021 CCR-DCEG FLEX Award was originally published by the National Cancer Institute.”